Publications by authors named "Ian A Rowe"

Claim this Profile
M
MELD 3. and the case for continuous updating in liver allocation.
Ian A Rowe, Juan G Abraldes

JHEP Rep· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal strategies to prevent disease progression and clinical events in MASLD.
Ian A Rowe

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: A prognostic model in patients with alcohol-associated cirrhosis does exist.
Vincent Haghnejad, Laura Burke, Siham El Ouahabi, Richard Parker, Ian A Rowe

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomes.
Ben Ward, Mark Theodoreson, Guruprasad Aithal, Michael Allison, Mayur Brahmania, Ian A Rowe

Hepatol Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control study.
Hannes Hegmar, Bonnie Bengtsson, Sofia Ullman, Ian A Rowe, Per Stål

Scand J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic review.
Vincent Haghnejad, Laura Burke, Siham El Ouahabi, Richard Parker, Ian A Rowe

Hepatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis.
Laura Burke, Alexander Hinkson, Vincent Haghnejad, Rebecca Jones, Richard Parker, Ian A Rowe

JHEP Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom.
Osvaldo Ulises Garay, Louisa Elena Ambühl, Thomas G Bird, Eleanor Barnes, William L Irving, Ian A Rowe

Value Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for clinical trials in MASH-related compensated cirrhosis.
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, Ramón Bataller, Annalisa Berzigotti, Ian A Rowe

Nat Rev Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis.
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, Ramón Bataller, Annalisa Berzigotti, Ian A Rowe

Nat Rev Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation.
William Bernal, Rhiannon Taylor, Ian A Rowe, Abhishek Chauhan, Matthew J Armstrong

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records.
Ignat Drozdov, Benjamin Szubert, Ian A Rowe, Timothy J Kendall, Jonathan A Fallowfield

Ann Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.
Anya Burton, Jennifer Wilburn, Robert J Driver, David Wallace, Sean McPhail, Ian A Rowe

Br J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
Anthony Attia, Jamie Webb, Katherine Connor, Chris J C Johnston, Michael Williams, Ian A Rowe

Lancet Healthy Longev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.
Hannes Hagström, Leon A Adams, Alina M Allen, Christopher D Byrne, Yoosoo Chang, Ian A Rowe

Hepatol Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of outcomes in patients with acute variceal bleeding.
Ian A Rowe

Hepatology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial.
Ian A Rowe, Càndid Villanueva, Jessica E Shearer, Ferran Torres, Agustín Albillos

Hepatology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the risks and benefits of policy action in NAFLD.
Ian A Rowe

J Hepatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK liver transplantation allocation algorithm: transplant benefit score - Authors' reply.
Ben M Stutchfield, Antony Attia, Ian A Rowe, Ewen M Harrison, Tim Gordon-Walker

Lancet· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease.
Ian A Rowe, Alina M Allen

Hepatology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases.
Alexander Hinkson, Hannah Lally, Hannah Gibson, Rebecca Jones, Ian A Rowe

Aliment Pharmacol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis.
Mark D Theodoreson, Guruprasad P Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Ian A Rowe

Liver Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implausible algorithm output in UK liver transplantation allocation scheme: importance of transparency.
Antony Attia, Ian A Rowe, Ewen M Harrison, Tim Gordon-Walker, Ben M Stutchfield

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of hepatocellular carcinoma to the national health service in England: a registry-based analysis.
Katherine Cullen, Mari Jones, Rhys D Pockett, Anya Burton, Timothy J S Cross, Ian A Rowe

BMJ Open Gastroenterol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
#
#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?
Kushala Wm Abeysekera, Jessica Shearer, Oliver D Tavabie, John F Dillon, Ian A Rowe

Frontline Gastroenterol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis